Developing a machine learning algorithm to predict psychotropic drugs-induced weight gain and the effectiveness of anti-obesity drugs in patients with severe mental illness: Protocol for a prospective cohort study
PLOS One · 2025
DOI: 10.1371/journal.pone.0324000 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift PLOS One, 2025. Verfasst von Hye Jun Lee und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Family Medicine, College of Medicine, Chung-Ang University, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Machine Learning, Weight Gain, Psychotropic Drugs, Anti-Obesity Agents. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Biomedical Research Institute, Chung-Ang University Hospital.
Abstract (Originalsprache)
Obesity is a global public health concern, often co-occurring in patients with severe mental illnesses. The impact of psychotropic drugs-induced weight gain is augmenting the disease burden and healthcare expenditure. However, predictors of psychotropic drug-induced weight gain and the efficacy of anti-obesity drugs remain underexplored. This study aims to develop a machine learning algorithm to predict both psychotropic drugs-induced weight gain and metabolic changes, and the potential of anti-obesity drugs. We plan to enroll 300 patients with severe mental illnesses, including schizophrenia, bipolar disorder, and major depressive disorder. In Phase 1, the study will predict weight gain and metabolic changes after the psychotropic treatment. Data on demographics, lifestyle, medical history, psychological factors, anthropometrics, and laboratory results will be collected at baseline and re-evaluated 24 weeks post-treatment. Participants classified as obese (body mass index ≥ 25 kg/m²) or overweight (body mass index of 23–24.9 kg/m²) at the 24-week follow-up will proceed to Phase 2, which focuses on predicting the promise of anti-obesity drugs. The study participants will receive anti-obesity medications for 24 weeks, and the same variables from Phase 1 will be reassessed. A machine learning model will be developed to predict both psychotropic drug-induced weight gain and anti-obesity medications that will be effective. The algorithm will be tailored to each patient to guide clinicians in personalizing psychiatric and obesity treatment plans. The clinical trial is registered with the Clinical Research Information Service, part of the WHO International Clinical Trials Registry Platform (approval number: KCT0009769).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Family Medicine, College of Medicine, Chung-Ang University, Seoul, Republic of Korea.
- Biomedical Research Institute, Chung-Ang University Hospital, Seoul, Republic of Korea.
- Department of Psychiatry, College of Medicine, Chung-Ang University, Seoul, Republic of Korea.
- Department of Artificial Intelligence, Chung-Ang University, Seoul, Republic of Korea.
ORCID-Profile: Hye Jun Lee, Na Yeon Kim, Da Seul Kim, Jung-Ha Kim, Sun Mi Kim
Förderung
- Biomedical Research Institute, Chung-Ang University Hospital
Zitieren
APA
Lee, H. J., Kim, N. Y., Kim, D. S., Kim, Y., Kim, J. H., Han, D. H., & Kim, S. M. (2025). Developing a machine learning algorithm to predict psychotropic drugs-induced weight gain and the effectiveness of anti-obesity drugs in patients with severe mental illness: Protocol for a prospective cohort study. PLOS One. https://doi.org/10.1371/journal.pone.0324000
Vancouver
Lee HJ, Kim NY, Kim DS, Kim Y, Kim JH, Han DH, et al. Developing a machine learning algorithm to predict psychotropic drugs-induced weight gain and the effectiveness of anti-obesity drugs in patients with severe mental illness: Protocol for a prospective cohort study. PLOS One. 2025. doi:10.1371/journal.pone.0324000
BibTeX
@article{Lee2025,
author = {Lee, Hye Jun and Kim, Na Yeon and Kim, Da Seul and Kim, Youngbin and Kim, Jung-Ha and Han, Doug Hyun and Kim, Sun Mi},
title = {Developing a machine learning algorithm to predict psychotropic drugs-induced weight gain and the effectiveness of anti-obesity drugs in patients with severe mental illness: Protocol for a prospective cohort study},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0324000}
}
EUVIMED